12
total announcements
544293.BO · 15 min delayed
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the availability of the audio recording of their earnings call held on 13 August 2026, in relation to their unaudited financial results for the quarter ended 30 June 2026. The recording is available on their website.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the availability of the audio recording of its earnings call held on 13 August 2026, discussing unaudited financial results for Q4 and FY26-27.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd published unaudited financial results for the quarter ended 30 June 2026, showing a total income of Rs. 441.96 crore, EBITDA of Rs. 58.93 crore, and a profit after tax of Rs. 18.62 crore. The company also announced changes in the fund management responsibilities for Sundaram Mutual Fund's schemes.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced its Q1 FY27 results, with revenue from operations at INR 876.5 Mn, a 21% YoY growth, and EBITDA margin of 36.0%. The company has expanded its network with new centres in West Bengal and Jharkhand, and its Suraksha Genomics business has grown 136% YoY.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Limited announced its unaudited financial results for the quarter ended 30 June 2026, with PAT growing by 40% year-on-year and EBITDA increasing by 28% year-on-year. The company's revenue grew 21% YoY in Q1 FY27, with EBITDA margin improving to 36.0%. Suraksha Genomics continued its strong growth trajectory, delivering revenue growth of 136% YoY in Q1 FY27.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has fixed a revised record date of 15 September 2026 for determining shareholder entitlement to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the appointment of Mr. Dinesh Gupta as the Chief Financial Officer (CFO) of the company, effective from 24 August 2026. The company has also approved the unaudited financial results for the quarter ended 30 June 2026 and fixed 15 September 2026 as the record date for the purpose of determining the entitlement of shareholders to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has approved unaudited financial results for the quarter ended 30 June 2026, with the results being made available on the company's website. The board also approved the appointment of Mr. Dinesh Gupta as the Chief Financial Officer, and fixed the record date for the purpose of determining the entitlement of shareholders to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd announced its unaudited financial results for the quarter ended 30 June, 2026, and the appointment of Mr. Dinesh Gupta as the Chief Financial Officer. The company also fixed the record date for the purpose of determining the entitlement of shareholders to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has postponed its 21st Annual General Meeting (AGM) scheduled for September 2, 2026, due to unavoidable circumstances. The revised date, time, and venue will be announced later, in accordance with applicable laws and regulations.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd will host a conference call on August 13, 2026, to discuss their Q1 FY27 results. The call will be held at 11:30 AM IST and will be attended by company officials. The call details and dial-in numbers are provided.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has informed BSE that a Board meeting is scheduled on 12/08/2026 to consider and approve unaudited financial results for the quarter ended 30 June 2026.